FRIDAY, Oct. 25, 2024 (HealthDay News) — Medication and behavioral therapy are both effective in combatting fatigue caused by multiple sclerosis (MS), either separately or together, a new study finds. MS patients felt significantly less fatigue after they were prescribed modafinil (Provigil), a drug that promotes wakefulness and is usedContinue Reading

FRIDAY, Oct. 24, 2024 (HealthDay News) — Certain gut microbes might be linked to a person’s risk of developing Parkinson’s disease, a new study suggests. People prescribed multiple courses of penicillin antibiotics have a modestly lower risk of developing Parkinson’s, researchers found. Those antibiotics might be affecting bacterial populations inContinue Reading

THURSDAY, Oct. 24, 2024 (HealthDay News) — Add Alzheimer’s disease to the list of conditions that might benefit from the revolutionary diabetes drug Ozempic, a new study says. People with type 2 diabetes taking semaglutide appeared to have a significantly lower risk of developing Alzheimer’s compared to patients taking sevenContinue Reading

WEDNESDAY, Oct. 23, 2024 (HealthDay News) — Women fighting breast cancer can relieve some of their chemotherapy “brain fog” through aerobic exercise, a new clinical trial in Canada suggests. Breast cancer patients on chemo who participated in a regular aerobics class reported that they felt sharper and had better qualityContinue Reading

FRIDAY, Oct. 18, 2024 (HealthDay News) — Depression can make it tougher for athletes to recover from a concussion, and vice versa, a new study finds. Student athletes who have both concussion and depression have significantly worse symptoms for both conditions, researchers reported recently in the journal Brain Research. What’sContinue Reading